China Life Insurance Company Limited — Earnings Preview
Key Factors to Watch Next Earnings
| Factor | Forward Consensus / Guidance | Last Year Actuals | YoY Comparable | Notes |
|---|---|---|---|---|
| Revenue ($M) | $111,927 | $90,551 | +23.6% | FY2024 actual, FY2026 consensus |
| Net Income ($M) | $25,002 | $14,756 | +69.6% | FY2024 actual, FY2026 consensus |
| EPS (GAAP) | $0.84 | $0.47 | +78.3% | FY2024 actual, FY2026 consensus |
| Value of New Business Growth | +26.3% | Tough comp | Q1 2024 actual, H1 2024 +18.6% | |
| Guaranteed Liability Cost | <3% avg | Lower YoY | Q2 2024 actual, guidance for further reduction | |
| Sales Force Productivity | +12.4% | Tough comp | H1 2024 actual | |
| Gross Investment Yield (%) | 3.59% | +26 bps | H1 2024 actual |
Summary and Conclusions
- China Life is coming off a strong FY2024 with revenue up +23.6% YoY and net income up +69.6% YoY.
- Consensus expects continued robust growth in FY2026, with revenue at $111,927M (+23.6% YoY) and net income at $25,002M (+69.6% YoY).
- EPS is expected to rise sharply to $0.84 from $0.47 last year (+78.3%).
- Key KPIs such as value of new business, sales force productivity, and gross investment yield all posted strong YoY gains in FY2024/H1 2024, setting a tough comparable for the next report.
- Management guidance signals further reduction in liability costs, continued focus on product diversification, and ongoing reforms in sales force quality and structure.
- Expense management, cost reduction, and efficiency improvements are expected to continue, with particular attention to bancassurance channel value ratio and participating insurance share.
- Dividend payout policy remains stable, with interim dividend paid and full-year payout to be determined based on performance, solvency, and regulatory requirements.
Core Results — Fiscal Year Trend
Income Statement — Annual
| Fiscal Year | Revenue ($M) | Net Income ($M) | EPS (GAAP) |
|---|---|---|---|
| 2026 (Consensus) | 111,927 | 25,002 | 0.84 |
| 2025 (Consensus) | 108,234 | 24,011 | 0.86 |
| 2024 (Actual) | 90,551 | 14,756 | 0.47 |
Operating KPIs — H1 2024
| Metric | H1 2024 Actual | YoY Change | Notes |
|---|---|---|---|
| Value of New Business ($M) | 32,260 | +18.6% | Embedded value up 11.4% |
| Sales Force Productivity | +12.4% | Per capita FYRP | |
| Gross Investment Yield (%) | 3.59 | +26 bps | Net investment yield 3.03% |
| Guaranteed Liability Cost (%) | <3.0 | Lower YoY | Guidance for further reduction |
Guidance Summary
Guidance — Soft Commentary (H2 2024 and FY2025/FY2026)
| Metric/Theme | Guidance / Management Commentary |
|---|---|
| Liability Cost | Guaranteed return cost for new business in 2025 will be lower by another 50 bps vs. 2024; overall target and guaranteed interest rate will trend down over next 2–3 years. |
| Expense Management | Company will vigorously reduce cost, balance volume and risk of new business development; fee difference management ongoing, results gradually unleashed. |
| Product Mix | Share of whole life and participating products will increase in 2025; traditional products will be smaller in share. |
| Sales Force Reform | Seed Program piloted in 24 cities, expansion underway; focus on high-caliber recruits, moderate team expansion, professionalization. |
| Bancassurance Channel | Value ratio improved by 13.4%; share of bancassurance in new business enlarged to 9% in H1 2024; steady increase expected. |
| Dividend Policy | Payout will continue on stable path; full-year payout to be determined based on performance, solvency, regulatory requirements. |
| Investment Strategy | Focus on long-term, prudent allocation; increased investment in high dividend shares; balanced and diversified approach. |
| Value of New Business | Proactive budget for new business in FY2025; company expects vigorous cost reduction and healthy direction of development. |
| Net Investment Yield | Decline will slow as interest rates stabilize; sound momentum expected. |
| Product Strategy | Further improvements on product strategy for future launches; emphasis on management of term and duration, customer-centric approach. |
Management Commentary
- On Liability Cost: "Guaranteed interest rate cost in 2024 must be lower than 2023 level by 50 bps on average. With further reduction for new business in 2025, guarantee cost will be lower by another 50 bps versus this year."
- On Product Mix: "Whole life and participating products will all be larger in share and the traditional products will be smaller in share."
- On Expense Management: "Fee difference management is much more than reduction of sales cost... technology empowerment, operational efficiency, back-office cost savings."
- On Sales Force: "Seed Program piloted in 24 cities... expansion underway, focus on high-caliber recruits, moderate team expansion, professionalization."
- On Dividend Policy: "Payout will continue on stable path; full-year payout to be determined based on performance, solvency, regulatory requirements."
What Changed
- Strong YoY growth in revenue, net income, and EPS in FY2024 sets a tough comparable for next earnings.
- Management signals further reduction in liability costs and increased share of participating/whole life products.
- Sales force reform and Seed Program expansion are ongoing, with focus on quality and productivity.
- Expense management and cost reduction remain priorities, especially in bancassurance channel.
- Dividend payout policy remains stable, with interim dividend paid and full-year payout to be determined.
Conclusion
China Life Insurance Company Limited is entering its next earnings report with strong momentum, coming off a robust FY2024. The company faces tough YoY comparables across revenue, net income, EPS, and key operating KPIs. Forward consensus expects continued growth, while management guidance emphasizes further reduction in liability costs, product diversification, expense management, and sales force reform. Investors should focus on the trajectory of liability costs, value of new business, sales force productivity, and dividend payout policy as key signals in the upcoming report.
